Partnership

A collaboration, not a contract…

ProteoCell places a premium on using its bioprocess development platform using a “partnership format.” This partnership philosophy is based on the belief that small and emerging biotechnology discovery companies lacking cell line engineering and bioprocess development capabilities need access to this platform before they advanced too far with their recombinant product development. ProteoCell combines its in-house R&D capabilities with client biomolecule production needs to develop the suitable production platform at the earliest stages of development, treating each project as a collaboration instead of a contract, eliminating costly, untimely, and cumbersome bioprocess change requirements later in the development process. ProteoCell’s strategy has already brought multiple clients/partners immeasurable savings in both cost and development timelines, distinguishing this approach from the rest of the bioprocess contract research and contract manufacturing industry.